(Q44122975)

English

Immunotherapy of glioblastoma with intratumoural administration of autologous lymphocytes and human lymphoblastoid interferon. A further clinical study

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Immunotherapy of glioblastoma with intratumoural administration of autologous lymphocytes and human lymphoblastoid interferon. A further clinical study (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

J Vaquero

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

R Martínez

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

J Ramiro

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

F G Salazar

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

L Barbolla

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

C Regidor

6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

publication date

1 January 1991

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Acta Neurochirurgica

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

109

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

42-45

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Human natural killer cells: biologic and pathologic aspects

1 reference

https://pubmed.ncbi.nlm.nih.gov/2068965

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intratumoral LAK cell and interleukin-2 therapy of human gliomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2068965

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of Natural Killer Cell Function by Glass-adherent Cells in patients with Primary Intracranial Malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/2068965

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intratumoural injection of autologous lymphocytes plus human lymphoblastoid interferon for the treatment of glioblastoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2068965

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer therapy with interleukin-2: immunologic manipulations can mediate the regression of cancer in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/2068965

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2068965

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/2068965

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous glioma transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2068965

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intrathecal injection of autologous leucocytes in glioblastoma: circulatory dynamics within the subarachnoid space and clinical results

1 reference

https://pubmed.ncbi.nlm.nih.gov/2068965

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2068965

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2068965

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive immunotherapy of human meningeal gliomatosis and carcinomatosis with LAK cells and recombinant interleukin-2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2068965

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histological changes in glioblastoma after intratumoral injection of autologous lymphocytes and human lymphoblastoid interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/2068965

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intralesional infusion of lymphokine-activated killer (LAK) cells and recombinant interleukin-2 (rIL-2) for the treatment of patients with malignant brain tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/2068965

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmentation of mouse natural killer cell activity by interferon and interferon inducers

1 reference

https://pubmed.ncbi.nlm.nih.gov/2068965

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Presence and significance of NK cells in glioblastomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2068965

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2068965

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive immunotherapy for recurrent glioblastoma multiforme using lymphokine activated killer cells and recombinant interleukin-2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2068965

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An adoptive immunotherapy of patients with medulloblastoma by lymphokine-activated killer cells (LAK).

1 reference

https://pubmed.ncbi.nlm.nih.gov/2068965

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon and spontaneous cytotoxicity in man. I. Enhancement of the spontaneous cytotoxicity of peripheral lymphocytes by human leukocyte interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/2068965

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy with autologous white cell infusions (“lymphocytes”) in the treatment of recurrent glioblastoma multiforme.A preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/2068965

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glioblastoma multiforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2068965

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01405696

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44122975&oldid=2206448873"